Goldman Sachs Group »

Nautilus Biotechnology shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $200k 67k 2.99
2023-09-30 $255k 81k 3.16
2023-06-30 $368k 95k 3.87
2023-03-31 $254k 92k 2.77
2022-12-31 $128k 71k 1.80
2022-06-30 $209k 78k 2.69
2022-03-31 $406k 94k 4.34
2021-12-31 $299k 58k 5.18
2021-09-30 $64k 10k 6.14